Law S Y, Fok M, Wong J
Department of Surgery, University of Hong Kong.
Br J Surg. 1996 Jan;83(1):107-11. doi: 10.1002/bjs.1800830134.
Patterns of disease recurrence were reviewed in 108 patients who had curative resection for squamous cell cancer of the thoracic oesophagus. At a median follow-up of 20 months, 56 patients (52 per cent) had recurrence. Most presented within 2 years. Extrathoracic recurrence was found in 41 per cent of patients and intrathoracic recurrence in 25 per cent. Systemic organ metastases (26 per cent) were as frequent as intrathoracic recurrences. Twelve patients (11 per cent) developed cervical lymph node (CLN) recurrence; their mean time to recurrence was 12.6 months, compared with 13.1 months for recurrence at locations other than the neck (P = 0.8). Median survival was 23 and 13 months respectively (P = 0.27). Preoperative chemotherapy lowered the recurrence rate from 60 per cent to 30 per cent, (P = 0.01) but did not affect survival. The addition of cervical lymphadenectomy would benefit few patients and must be counterbalanced with increased morbidity and cost. The frequency of systemic organ metastases calls for further investigation of the possible benefits of chemotherapy.
对108例行胸段食管癌根治性切除术的患者的疾病复发模式进行了回顾。中位随访20个月时,56例患者(52%)出现复发。大多数在2年内复发。41%的患者出现胸外复发,25%的患者出现胸内复发。全身器官转移(26%)与胸内复发的频率相同。12例患者(11%)发生颈部淋巴结(CLN)复发;其复发的平均时间为12.6个月,而颈部以外部位复发的平均时间为13.1个月(P = 0.8)。中位生存期分别为23个月和13个月(P = 0.27)。术前化疗将复发率从60%降至30%(P = 0.01),但不影响生存率。增加颈部淋巴结清扫术对少数患者有益,且必须与发病率增加和成本增加相权衡。全身器官转移的频率要求进一步研究化疗可能带来的益处。